Girindus America

Dr. Edward Huber has been named director of Analytical Development and Quality Control, Girindus. Dr. Huber will provide managerial and technical leadership in the areas of analytical development and quality control. He has 30 years of pharmaceutical experience in the area of structural elucidation, separations sciences, and the development and validation of analytical methods for the characterization and control of APIs and finished dosage forms.

Dr. Huber has held positions of increasing responsibility in analytical chemistry at Marion Merrell Dow, Hoechst Marion Roussel, Aventis and Patheon. Most recently he was director of Analytical Development within Patheon’s Pharmaceutical Development Services group.

“We are very pleased to have Ed on the Girindus leadership team,” said Dr. Mark Laskovics, Girindus president and chief operating officer. “We welcome his extensive expertise in both the technical and managerial areas of QC / Analytics which will reinforce the high quality and technical standards Girindus has achieved to date.”